Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Barnett

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International MS Journal|August 13, 2009
MS: is it one disease?M H Barnett, J D E Parratt, J D Pollard, et al.
Neurology|March 14, 2012
The evidence for a role of B cells in multiple sclerosisG Disanto, J M Morahan, M H Barnett, et al.
AJNR. American Journal of Neuroradiology|June 15, 2013
Conventional and advanced imaging in neuromyelitis opticaY Barnett, I J Sutton, M Ghadiri, et al.
Therapeutic Advances in Neurological Disorders|February 6, 2019
Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?H N Beadnall, C Wang, W Van Hecke, et al.
Multiple Sclerosis and Related Disorders|March 27, 2018
The evolution of "No Evidence of Disease Activity" in multiple sclerosisG Lu, H N Beadnall, J Barton, et al.
Neurology|February 26, 2000
Chronic ophthalmoplegia with anti-GQ1b antibodyS W Reddel, M H Barnett, W X Yan, et al.
Journal of Neurology|January 21, 2003
Paraneoplastic brainstem encephalitis and anti-Ri antibodiesI J Sutton, M H Barnett, J D G Watson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2011
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapyM H Barnett, J W Prineas, M E Buckland, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2016
Automated brain volumetrics in multiple sclerosis: a step closer to clinical applicationC Wang, H N Beadnall, S N Hatton, et al.
Journal of the Neurological Sciences|December 21, 2010
Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndromeT A Hardy, R J Garsia, G M Halmagyi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International MS Journal|August 13, 2009
MS: is it one disease?M H Barnett, J D E Parratt, J D Pollard, et al.
Neurology|March 14, 2012
The evidence for a role of B cells in multiple sclerosisG Disanto, J M Morahan, M H Barnett, et al.
AJNR. American Journal of Neuroradiology|June 15, 2013
Conventional and advanced imaging in neuromyelitis opticaY Barnett, I J Sutton, M Ghadiri, et al.
Therapeutic Advances in Neurological Disorders|February 6, 2019
Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?H N Beadnall, C Wang, W Van Hecke, et al.
Multiple Sclerosis and Related Disorders|March 27, 2018
The evolution of "No Evidence of Disease Activity" in multiple sclerosisG Lu, H N Beadnall, J Barton, et al.
Neurology|February 26, 2000
Chronic ophthalmoplegia with anti-GQ1b antibodyS W Reddel, M H Barnett, W X Yan, et al.
Journal of Neurology|January 21, 2003
Paraneoplastic brainstem encephalitis and anti-Ri antibodiesI J Sutton, M H Barnett, J D G Watson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2011
Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapyM H Barnett, J W Prineas, M E Buckland, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2016
Automated brain volumetrics in multiple sclerosis: a step closer to clinical applicationC Wang, H N Beadnall, S N Hatton, et al.
Journal of the Neurological Sciences|December 21, 2010
Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndromeT A Hardy, R J Garsia, G M Halmagyi, et al.
Pageof 3